Biotalys Reports Half-Year 2022 Financial Results and Business Highlights


Ghent, Belgium, Aug. 19, 2022 (GLOBE NEWSWIRE) —

Biotalys Reports Half-Year 2022 Financial Results and Business Highlights

  • Established strategic partnerships, paving the way for market calibration in the U.S. of Biotalys’ first biocontrol product Evoca™*

  • Realized R&D breakthrough for Evoca, increasing the commercial potential of the product by 2026

  • Expanded Executive and Board leadership

  • Cash and cash equivalents amounted to €45.6 million end of June 2022

  • Management to host a conference call at 16:00 CEST / 15:00 BST / 10:00 EDT today, details below

Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions, today announces its key business achievements and consolidated financial results for the first half of 2022, prepared in accordance with International Accounting Standard 34 ‘Interim Financial Reporting’ as adopted by the European Union. The full interim financial report is available here on the Biotalys website.

Patrice Sellès, Chief Executive Officer of Biotalys, commented: “Biotalys continues to forge the path toward a safer, more sustainable food supply by building a strong product pipeline, an exceptionally talented team and a global partner network. As we are coming closer towards the regulatory approval of our first biocontrol Evoca, the continued positive feedback the product has earned both in the field and from renowned industry experts has created great excitement…

Read more…